PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
PFA tumours express high levels of EZHIP (also known as CXORF67). Here the authors find that EZHIP directly interacts with the active site of EZH2 and is a competitive inhibitor of PRC2 and that EZHIP gives rise to H3K27me3 genomic profile similar to the K27M oncohistone.
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a64b34bead04eeeabaa7ea08c232938 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7a64b34bead04eeeabaa7ea08c232938 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7a64b34bead04eeeabaa7ea08c2329382021-12-02T17:01:26ZPFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism10.1038/s41467-019-09981-62041-1723https://doaj.org/article/7a64b34bead04eeeabaa7ea08c2329382019-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-09981-6https://doaj.org/toc/2041-1723PFA tumours express high levels of EZHIP (also known as CXORF67). Here the authors find that EZHIP directly interacts with the active site of EZH2 and is a competitive inhibitor of PRC2 and that EZHIP gives rise to H3K27me3 genomic profile similar to the K27M oncohistone.Siddhant U. JainTruman J. DoPeder J. LundAndrew Q. RashoffKatharine L. DiehlMarcin CieslikAndrea BajicNikoleta JureticShriya DeshmukhSriram VennetiTom W. MuirBenjamin A. GarciaNada JabadoPeter W. LewisNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-14 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Siddhant U. Jain Truman J. Do Peder J. Lund Andrew Q. Rashoff Katharine L. Diehl Marcin Cieslik Andrea Bajic Nikoleta Juretic Shriya Deshmukh Sriram Venneti Tom W. Muir Benjamin A. Garcia Nada Jabado Peter W. Lewis PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism |
description |
PFA tumours express high levels of EZHIP (also known as CXORF67). Here the authors find that EZHIP directly interacts with the active site of EZH2 and is a competitive inhibitor of PRC2 and that EZHIP gives rise to H3K27me3 genomic profile similar to the K27M oncohistone. |
format |
article |
author |
Siddhant U. Jain Truman J. Do Peder J. Lund Andrew Q. Rashoff Katharine L. Diehl Marcin Cieslik Andrea Bajic Nikoleta Juretic Shriya Deshmukh Sriram Venneti Tom W. Muir Benjamin A. Garcia Nada Jabado Peter W. Lewis |
author_facet |
Siddhant U. Jain Truman J. Do Peder J. Lund Andrew Q. Rashoff Katharine L. Diehl Marcin Cieslik Andrea Bajic Nikoleta Juretic Shriya Deshmukh Sriram Venneti Tom W. Muir Benjamin A. Garcia Nada Jabado Peter W. Lewis |
author_sort |
Siddhant U. Jain |
title |
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism |
title_short |
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism |
title_full |
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism |
title_fullStr |
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism |
title_full_unstemmed |
PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism |
title_sort |
pfa ependymoma-associated protein ezhip inhibits prc2 activity through a h3 k27m-like mechanism |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/7a64b34bead04eeeabaa7ea08c232938 |
work_keys_str_mv |
AT siddhantujain pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT trumanjdo pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT pederjlund pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT andrewqrashoff pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT katharineldiehl pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT marcincieslik pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT andreabajic pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT nikoletajuretic pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT shriyadeshmukh pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT sriramvenneti pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT tomwmuir pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT benjaminagarcia pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT nadajabado pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism AT peterwlewis pfaependymomaassociatedproteinezhipinhibitsprc2activitythroughah3k27mlikemechanism |
_version_ |
1718382153257975808 |